The Kerala State Drugs Control Department has banned the distribution and sale of several batches of medicines found to be of substandard quality during quality checks conducted at its laboratories in ...

Scientists have developed a long-acting injectable treatment combining levodopa and carbidopa, the two medications used to treat Parkinson’s, which could transform how the disease is treated.

Injection site reactions can occur due to vaccines, Botox, biologics, and chemotherapy. Symptoms often include swelling and itching at the injection site.

Deafness reversed: Single injection brings hearing back within weeks Date: July 3, 2025 Source: Karolinska Institutet Summary: A cutting-edge gene therapy has significantly restored hearing in ...

Medical pros beg people to avoid viral ‘Innotox’ trend — which can cause muscle paralysis and even death ...

A newly approved twice-yearly injection for HIV prevention has rejuvenated hope in the national and global drive to end HIV/Aids as a public health threat by 2030. Lenacapavir, the groundbreaking ...

Fuel injection offers drivers increased efficiency and power. But there's a common problem, too: carbon buildup on the engine's intake valves.

Sean Manaea’s return has been delayed yet again. The Mets left-hander complained of left elbow discomfort following his most recent rehab outing.

Discover how sclerotherapy treats spider veins and small varicose veins. Read ahead to know more as an expert explains the process, benefits, and who should avoid it.

The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents.